OR WAIT 15 SECS
© 2021 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.
Irvine, Calif. - Allergan has announced it has entered an agreement with QLT USA to purchase Aczone (dapsone) Gel 5 percent, according to socalTech.com.
Irvine, Calif.
- Allergan has announced it has entered an agreement with QLT USA to purchase Aczone (dapsone) Gel 5 percent, according to socalTech.com.
Allergan will pay about $150 million for all assets related to Aczone, a topical treatment for acne vulgaris, which could reach revenues in excess of $75 million per year.